IDD researchers focus on the discovery and development of new therapies for treating patients with cancer through the integration of research programs in the basic, translational and clinical sciences. The IDD Basic Research Department is directed toward the application of advanced genetic technologies to cancer drug development.
Research is focused on prevention, model systems, and therapy.
Prevention research concentrates on early detection of genetic risk factors and the evaluation of preventive measures, including antioxidant-based cancer prevention drugs. The Translational Research Department is a key gateway by which a substantial number of new molecular entities enter the IDD research environment. One major focus in this unit is the evaluation of these experimental compounds in tumor models, which provide the most relevant data for new anticancer agents with respect to historical predictability. These models are used in experiments designed to test both standard and newer therapies. The program provides wide experience in conducting drug studies.